Report from the melanoma independent board first melanoma MIB conference, 21-22 October 2013

Alessandro Testori, P. Ascierto, V. Chiarion Sileni, F. De Lorenzo, P. G. Pelicci, C. R. Rossi

Research output: Contribution to journalArticle

Abstract

The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other's points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments.

Original languageEnglish
Article number440
Journalecancermedicalscience
Volume8
Issue number1
DOIs
Publication statusPublished - Jun 30 2014

    Fingerprint

Keywords

  • Cost-effective treatment
  • Melanoma
  • New therapies
  • Treatment guidelines

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this